No adverse reactions have been reported yet. 1 lot is affected due to undeclared fluoxetine in the AM tablets and 2,4-dinitrophenol (DNP) in the PM tablets. Products were sold online to consumers nationwide. Consumers should stop using the product immediately and should not sell, give, or transfer it to others.
Who's At Risk?
Consumers using the product for weight loss, particularly those taking certain other medications that may increase the risk of fatal cardiac events.
Symptoms
May cause nausea, vomiting, sweating, dizziness, headaches, dangerous heart rhythm problems, rapid heart rate, cardiac arrest, seizures, abnormal bleeding, suicidal thoughts, dangerously high body temperature, and rapid breathing.
